Michael D. Lockshin

Last updated
Michael D. Lockshin
Born (1937-12-09) December 9, 1937 (age 85)
Nationality American
Alma mater Harvard Medical School
Occupation Physician, Scientist
Known for Autoimmune diseases
Scientific career
Institutions Hospital for Special Surgery

Michael D. Lockshin is an American professor and medical researcher. He is known for his work as a researcher of autoimmune diseases, with focus on antiphospholipid syndrome and lupus. He is Professor Emeritus of Medicine and the Director Emeritus of the Barbara Volcker Center for Women and Rheumatic Disease at Hospital for Special Surgery. He retired from HSS on January 31st, 2023.

Contents

Lockshin's twin brother, Richard A. Lockshin, is an American cellular biologist known for his work on apoptosis.

Education and training

Lockshin graduated cum laude from Harvard College in 1959 with an AB in history and literature. He received his MD in 1963 from Harvard Medical School. Lockshin interned and did his residency at Bellevue Hospital and the Memorial Sloan Kettering Cancer Center and his fellowship in rheumatic diseases at Columbia Presbyterian Medical Center in New York City.

Work

Lockshin's long-term research interest is in the clinical aspects of systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS), pregnancy in rheumatic disease patients, gender and rheumatic disease, and neurological SLE.

He has written three books for the general reading public. Guarded Prognosis: A Doctor and his Patients Talk about Chronic Disease and How to Cope With It (Hill and Wang, a division of Farrar, Straus and Giroux) was published in 1998. Dancing at the River’s Edge: A Patient and Her Doctor Negotiate a Life With Chronic Illness is a personal dual memoir, written in collaboration with long-time patient Alida Brill. His latest book, The Prince at the Ruined Tower: Time, Uncertainty & Chronic Illness explores seldom discussed issues of contemporary medical practice, such as how patients, doctors, insurers, and administrators should and do respond when diagnoses are uncertain.

Lockshin has authored nearly 300 scientific papers, book chapters, and books and has edited several conference proceedings and books. In addition, he co-authored the first reports on hepatitis B–associated polyarteritis nodosa; early reports on twins with lupus; studies on neurologic lupus, including treatment and cognitive dysfunction; pregnancy and lupus; atherosclerosis and lupus, and many research papers on the antiphospholipid antibody syndrome. He convened the first International Conference on Pregnancy and Rheumatic Disease and, though the Barbara Volker Center, the first Conference on Gender, Biology, and Human Disease. His research has been supported by grants from NIAMS, the Arthritis Foundation, the SLE Foundation, and private donors throughout his academic career.

Lockshin served as editor-in-chief of Arthritis & Rheumatism for five years. [1] He has served on the editorial board of the Journal of Rheumatology, and as a reviewer for the New England Journal of Medicine, the Journal of Clinical Investigation, and the Journal of Immunology, among other scientific journals.

Lockshin held senior management positions at the National Institutes of Health in Bethesda, Maryland. He served first as director of the Extramural Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and then as acting director of the Institute. This Institute is responsible for U.S. government research funding in the fields of rheumatology and dermatology. He also served as Senior Advisor to the Director at the NIH's Clinical Center.

Honors

Lockshin received the Lupus Foundation of America's 2012 National Leadership Award for Lupus Medical Advancement and a Lifetime Achievement Award from the New York Arthritis Foundation in 2008. He was named a master of the American College of Rheumatology in 2003 and a Research Hero of the Arthritis Foundation in 2001. He is an honorary faculty member of Alpha Omega Alpha.

Committee membership

Lockshin has served on numerous study sections and ad hoc committees for the National Institutes of Health, the Veterans' Administration, the Canadian Arthritis and Rheumatism Society, the Canadian Medical Research Council, the SLE Foundation, among others. He chaired the American Board of Internal Medicine's Sub Specialty Committee on Rheumatology and the American College of Physicians' Medical Knowledge Self-Assessment Program. He chaired the Arthritis Foundation's Professional Education and Unproven Remedies Committees and the American College of Rheumatology's Education Committee. He chaired the ACR's Audiovisual Aids Committee that produced the first Clinical Slide Collection in rheumatology.

Books

Related Research Articles

<span class="mw-page-title-main">Sjögren syndrome</span> Autoimmune disease which affects the bodys moisture glands

Sjögren syndrome or Sjögren's syndrome is a long-term autoimmune disease that affects the body's moisture-producing glands, and often seriously affects other organ systems, such as the lungs, kidneys, and nervous system.

Rheumatology is a branch of medicine devoted to the diagnosis and management of disorders whose common feature is inflammation in the bones, muscles, joints, and internal organs. Rheumatology covers more than 100 different complex diseases, collectively known as rheumatic diseases, which includes many forms of arthritis as well as lupus and Sjögren's syndrome. Doctors who have undergone formal training in rheumatology are called rheumatologists.

<span class="mw-page-title-main">Antiphospholipid syndrome</span> Medical condition

Antiphospholipid syndrome, or antiphospholipid antibody syndrome, is an autoimmune, hypercoagulable state caused by antiphospholipid antibodies. APS provokes blood clots (thrombosis) in both arteries and veins as well as pregnancy-related complications such as miscarriage, stillbirth, preterm delivery, and severe preeclampsia. Although the exact etiology of APS is still not clear, genetics is believed to play a key role in the development of the disease. The diagnostic criteria require one clinical event and two positive blood test results spaced at least three months apart that detect lupus anticoagulant, anti-apolipoprotein antibodies, or anti-cardiolipin antibodies.

<span class="mw-page-title-main">Antinuclear antibody</span> Autoantibody that binds to contents of the cell nucleus

Antinuclear antibodies are autoantibodies that bind to contents of the cell nucleus. In normal individuals, the immune system produces antibodies to foreign proteins (antigens) but not to human proteins (autoantigens). In some cases, antibodies to human antigens are produced.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is one of the institutes and centers that make up the National Institutes of Health, an agency of the United States Department of Health and Human Services (HHS).

Rheumatism or rheumatic disorders are conditions causing chronic, often intermittent pain affecting the joints or connective tissue. Rheumatism does not designate any specific disorder, but covers at least 200 different conditions, including arthritis and "non-articular rheumatism", also known as "regional pain syndrome" or "soft tissue rheumatism". There is a close overlap between the term soft tissue disorder and rheumatism. Sometimes the term "soft tissue rheumatic disorders" is used to describe these conditions.

Mixed connective tissue disease, commonly abbreviated as MCTD, is an autoimmune disease characterized by the presence of elevated blood levels of a specific autoantibody, now called anti-U1 ribonucleoprotein (RNP) together with a mix of symptoms of systemic lupus erythematosus (SLE), scleroderma, and polymyositis. The idea behind the "mixed" disease is that this specific autoantibody is also present in other autoimmune diseases such as systemic lupus erythematosus, polymyositis, scleroderma, etc. MCTD was characterized as an individual disease in 1972 by Sharp et al., and the term was introduced by Leroy in 1980.

Palindromic rheumatism (PR) is a syndrome characterised by recurrent, self-resolving inflammatory attacks in and around the joints, and consists of arthritis or periarticular soft tissue inflammation. The course is often acute onset, with sudden and rapidly developing attacks or flares. There is pain, redness, swelling, and disability of one or multiple joints. The interval between recurrent palindromic attacks and the length of an attack is extremely variable from few hours to days. Attacks may become more frequent with time but there is no joint damage after attacks. It is thought to be an autoimmune disease, possibly an abortive form of rheumatoid arthritis.

Betty Diamond is an American physician and researcher. She is director of the Institute of Molecular Medicine at Northwell Health's Feinstein Institute for Medical Research in Manhasset, NY. She was elected a member of the National Academy of Sciences in 2022.

<span class="mw-page-title-main">Lupus</span> Human autoimmune disease

Lupus, technically known as systemic lupus erythematosus (SLE), is an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue in many parts of the body. Symptoms vary among people and may be mild to severe. Common symptoms include painful and swollen joints, fever, chest pain, hair loss, mouth ulcers, swollen lymph nodes, feeling tired, and a red rash which is most commonly on the face. Often there are periods of illness, called flares, and periods of remission during which there are few symptoms.

Lupus and pregnancy can present some particular challenges for both mother and child.

Ephraim Engleman was an American rheumatologist and a Clinical Professor of Medicine at the University of California, San Francisco. He had a major national and international impact on rheumatology during more than six decades, and wrote more than one hundred scientific and medical papers.

<span class="mw-page-title-main">Jaccoud arthropathy</span> Medical condition

Jaccoud arthropathy (JA), is a chronic non-erosive reversible joint disorder that may occur after repeated bouts of arthritis. It is caused by inflammation of the joint capsule and subsequent fibrotic retraction, causing ulnar deviation of the fingers, through metacarpophalangeal joint (MCP) subluxation, primarily of the ring and little-finger. Joints in the feet, knees and shoulders may also get affected. It is commonly associated with systemic lupus erythematosus (SLE), and occurs in roughly 5% of all cases.

Amita Aggarwal is an Indian clinical immunologist, rheumatologist and a Professor and Head at the Department of Clinical Immunology and Rheumatology of the Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow. Known for her studies in autoimmune rheumatic diseases, Aggarwal is a recipient of the Shakuntala Amir Chand Award of the Indian Council of Medical Research and an elected fellow of the National Academy of Sciences, India, National Academy of Medical Sciences and the National Academy of Medical Sciences. The Department of Biotechnology of the Government of India awarded her the National Bioscience Award for Career Development, one of the highest Indian science awards, for her contributions to biosciences in 2004.

Daniel Jeffrey Wallace is an American rheumatologist, clinical professor, author, and fellow. Wallace has published 500 peer reviewed publications, 9 textbooks, and 28 book chapters on topics such as lupus, Sjögren syndrome, osteoarthritis, and fibromyalgia. He has the largest cohort of lupus patients in the United States (2000). A full professor of medicine, he is associate director of the Rheumatology Fellowship Program at Cedars-Sinai. His seminal contributions to research include being an author of the first paper to demonstrate vitamin D dysfunction and the importance of interleukin 6 in lupus, conducting the first large studies of apheresis in rheumatoid arthritis and lupus, and insights into the mechanisms of action of antimalarials. Wallace's research accomplishments also include conducting many clinical rheumatic disease trials, examining the role of microvascular angina and accelerated atherogenesis in lupus, and work on anti-telomere antibodies which have garnered him 6 papers in The New England Journal of Medicine. Wallace's monograph, The Lupus Book, has sold over 100,000 copies since 1995.

<span class="mw-page-title-main">Robert G. Lahita</span> American physician

Robert George Lahita is an American physician, internist and rheumatologist, best known for his research into systemic lupus erythematosus. and other autoimmune diseases. He is the author of more than 16 books and 150 scientific publications in the field of autoimmunity and immuno-endocrinology and a media consultant on health-related issues. He currently serves as Director of the Institute of Autoimmune and Rheumatic Diseases at St. Joseph's Healthcare System, specializing in autoimmunity, rheumatology, and treatment of diseases of joints, muscle, bones and tendons including arthritis, back pain, muscle strains, common athletic injuries and collagen diseases.

Ianalumab is a monoclonal antibody that is being investigated for autoimmune hepatitis, multiple sclerosis, pemphigus vulgaris, rheumatoid arthritis, Sjögren syndrome, and systemic lupus erythematosus.

Dafna D. Gladman, MD, FRCPC, is a Canadian doctor and medical researcher working in the fields of psoriatic arthritis, systemic lupus erythematosus, and rheumatoid arthritis. She is a professor at the University of Toronto Faculty of Medicine and Senior Scientist at the Krembil Research Institute. She is Deputy Director, Centre for Prognosis Studies in the Rheumatic Diseases, Co-Director, Lupus Clinic, Toronto Western Hospital (TWH) and Director, Psoriatic Arthritis Program, Toronto Western Hospital.

George C. Tsokos is an American immunologist who is a professor of medicine at Harvard Medical School and is the chief at Division of Rheumatology and Clinical Immunology at Beth Israel Deaconess Medical Center; Boston, MA

<span class="mw-page-title-main">Robert H. Carter</span>

Robert H. Carter is an American rheumatologist and physician-scientist serving as the deputy director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) since 2008. He was the acting director of NIAMS from December 2018 until February 2021.

References

  1. Tindall, Elizabeth A. (July 2005). "Introducing the new editor of Arthritis & Rheumatism, Michael D. Lockshin, MD". Arthritis & Rheumatism. 52 (7): 1951. doi:10.1002/art.21275. ISSN   0004-3591.